PortfoliosLab logoPortfoliosLab logo
CLOV vs. LUMN
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

CLOV vs. LUMN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CLOV vs. LUMN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
CLOV
Clover Health Investments, Corp.
-27.66%-25.40%230.85%2.43%-75.01%-77.82%64.41%
LUMN
Lumen Technologies, Inc.
-9.01%46.33%190.16%-64.94%-55.48%38.82%1.26%

Fundamentals

Market Cap

CLOV:

$879.30M

LUMN:

$7.04B

EPS

CLOV:

-$0.17

LUMN:

-$1.75

PS Ratio

CLOV:

0.45

LUMN:

0.57

Total Revenue (TTM)

CLOV:

$1.92B

LUMN:

$12.40B

Gross Profit (TTM)

CLOV:

$1.99B

LUMN:

$3.02B

EBITDA (TTM)

CLOV:

-$83.86M

LUMN:

$1.32B

Returns By Period

In the year-to-date period, CLOV achieves a -27.66% return, which is significantly lower than LUMN's -9.01% return.


CLOV

1D
-3.41%
1M
-16.67%
YTD
-27.66%
6M
-35.11%
1Y
-52.65%
3Y*
26.24%
5Y*
-25.44%
10Y*

LUMN

1D
1.73%
1M
3.97%
YTD
-9.01%
6M
16.47%
1Y
84.11%
3Y*
38.69%
5Y*
-9.39%
10Y*
-8.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLOV vs. LUMN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
CLOV Risk / Return Rank: 77
Overall Rank
CLOV Sharpe Ratio Rank: 88
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 99
Sortino Ratio Rank
CLOV Omega Ratio Rank: 1010
Omega Ratio Rank
CLOV Calmar Ratio Rank: 44
Calmar Ratio Rank
CLOV Martin Ratio Rank: 44
Martin Ratio Rank

LUMN
LUMN Risk / Return Rank: 7373
Overall Rank
LUMN Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
LUMN Sortino Ratio Rank: 7575
Sortino Ratio Rank
LUMN Omega Ratio Rank: 7373
Omega Ratio Rank
LUMN Calmar Ratio Rank: 7373
Calmar Ratio Rank
LUMN Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. LUMN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLOVLUMNDifference

Sharpe ratio

Return per unit of total volatility

-0.80

1.04

-1.84

Sortino ratio

Return per unit of downside risk

-1.13

1.88

-3.01

Omega ratio

Gain probability vs. loss probability

0.86

1.24

-0.37

Calmar ratio

Return relative to maximum drawdown

-0.95

1.70

-2.65

Martin ratio

Return relative to average drawdown

-1.73

3.53

-5.27

CLOV vs. LUMN - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is -0.80, which is lower than the LUMN Sharpe Ratio of 1.04. The chart below compares the historical Sharpe Ratios of CLOV and LUMN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


CLOVLUMNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.80

1.04

-1.84

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.29

-0.11

-0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.31

0.16

-0.47

Correlation

The correlation between CLOV and LUMN is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

CLOV vs. LUMN - Dividend Comparison

Neither CLOV nor LUMN has paid dividends to shareholders.


TTM20252024202320222021202020192018201720162015
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LUMN
Lumen Technologies, Inc.
0.00%0.00%0.00%0.00%14.37%7.97%10.26%7.57%14.26%12.95%9.08%8.59%

Drawdowns

CLOV vs. LUMN - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, roughly equal to the maximum LUMN drawdown of -95.26%. Use the drawdown chart below to compare losses from any high point for CLOV and LUMN.


Loading graphics...

Drawdown Indicators


CLOVLUMNDifference

Max Drawdown

Largest peak-to-trough decline

-97.19%

-95.26%

-1.93%

Max Drawdown (1Y)

Largest decline over 1 year

-55.50%

-47.34%

-8.16%

Max Drawdown (5Y)

Largest decline over 5 years

-97.19%

-92.86%

-4.33%

Max Drawdown (10Y)

Largest decline over 10 years

-94.53%

Current Drawdown

Current decline from peak

-92.33%

-65.79%

-26.54%

Average Drawdown

Average peak-to-trough decline

-76.31%

-27.51%

-48.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.35%

22.76%

+7.59%

Volatility

CLOV vs. LUMN - Volatility Comparison

The current volatility for Clover Health Investments, Corp. (CLOV) is 11.86%, while Lumen Technologies, Inc. (LUMN) has a volatility of 14.70%. This indicates that CLOV experiences smaller price fluctuations and is considered to be less risky than LUMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


CLOVLUMNDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.86%

14.70%

-2.84%

Volatility (6M)

Calculated over the trailing 6-month period

47.56%

61.67%

-14.11%

Volatility (1Y)

Calculated over the trailing 1-year period

65.92%

81.11%

-15.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

89.37%

84.23%

+5.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.98%

66.92%

+19.06%

Financials

CLOV vs. LUMN - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Lumen Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
487.71M
3.04B
(CLOV) Total Revenue
(LUMN) Total Revenue
Values in USD except per share items